Industry Experts

Andrew Skora is Co-Founder and Senior Director of Research and Development at AbVir Biotherapeutics, where he leads antibody discovery and engineering, including AI-assisted candidate evaluation. He brings over 15 years of research experience spanning antibody engineering, oncology, and translational science. At Eli Lilly, he led teams advancing protein engineering campaigns across multiple formats and therapeutic areas through development-candidate nomination. At Viracta, he led translational research and biomarker strategy. During postdoctoral training with Bert Vogelstein at Johns Hopkins, he developed foundational MANAbody technology that contributed to Clasp Therapeutics’ pHLAre platform. He integrates molecular design, biological function, and developability for candidate selection.